Department of Medical Biotechnologies and Translational Medicine, University of Milan, 20089 Rozzano, Milan, Italy.
Sci Signal. 2013 Apr 30;6(273):ra30.1-11, S1-3. doi: 10.1126/scisignal.2003627.
Chemokines promote the recruitment of leukocytes to sites of infection and inflammation by activating conventional heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs). Chemokines are also recognized by a set of atypical chemokine receptors (ACRs), which cannot induce directional cell migration but are required for the generation of chemokine gradients in tissues. ACRs are presently considered "silent receptors" because no G protein-dependent signaling activity is observed after their engagement by cognate ligands. We report that engagement of the ACR D6 by its ligands activates a β-arrestin1-dependent, G protein-independent signaling pathway that results in the phosphorylation of the actin-binding protein cofilin through the Rac1-p21-activated kinase 1 (PAK1)-LIM kinase 1 (LIMK1) cascade. This signaling pathway is required for the increased abundance of D6 protein at the cell surface and for its chemokine-scavenging activity. We conclude that D6 is a signaling receptor that exerts its regulatory function on chemokine-mediated responses in inflammation and immunity through a distinct signaling pathway.
趋化因子通过激活传统的异三聚体鸟苷酸结合蛋白(G 蛋白)偶联受体(GPCR)来促进白细胞向感染和炎症部位的募集。趋化因子也被一组非典型趋化因子受体(ACRs)识别,ACRs 不能诱导细胞定向迁移,但对于在组织中产生趋化因子梯度是必需的。ACRs 目前被认为是“沉默受体”,因为在其配体结合后,没有观察到依赖 G 蛋白的信号活性。我们报告说,其配体与 ACR D6 的结合激活了 β-arrestin1 依赖性、G 蛋白非依赖性信号通路,导致肌动蛋白结合蛋白丝切蛋白通过 Rac1-p21 激活激酶 1(PAK1)- LIM 激酶 1(LIMK1)级联反应的磷酸化。该信号通路是 D6 蛋白在细胞表面丰度增加和趋化因子清除活性所必需的。我们得出结论,D6 是一种信号受体,通过一种独特的信号通路,在炎症和免疫中的趋化因子介导的反应中发挥其调节功能。